PHIA Koninklijke Philips N.V.

Philips celebrates 1.9m liters of helium saved as it marks 1,111 helium-free MRI operations installs, expanding care to more patients in more locations

Philips celebrates 1.9m liters of helium saved as it marks 1,111 helium-free MRI operations installs, expanding care to more patients in more locations

May 30, 2024

First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico

Amsterdam, the Netherlands and Bayamón, Puerto Rico (NYSE: PHG, AEX: PHIA), a global leader in health technology, and world leader in proven helium-free [1] MRI operations, today announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet, which took place in Puerto Rico’s Vida Imaging & Breast Center (Bayamón, Puerto Rico). Beyond its economic and sustainability benefits [2], helium-free MRI operations also increase resilience in the face of the tropical storms that hit Puerto Rico every year delivering quality care to patients who may otherwise not have access to advanced MRI scanning.

“The installation of our Philips MR 5300 scanner, with a 70cm bore and equipped with the 1,111th BlueSeal magnet at Vida Imaging & Breast Center in Puerto Rico is a testament to the global adoption of our innovative technology. Since 2018, Philips has been the first to provide helium-free MR operations worldwide, improving access to better care for more patients, and we will continue to drive innovation in this space,” said Ruud Zwerink, Business Leader of MR at Philips. “BlueSeal magnet technology has proven to be the system of choice for improved diagnostic capabilities, while providing an answer to , saving approximately 1.9 million liters of liquid helium to date.”

A BlueSeal magnet’s ability to be shut down and re-energized in a controlled way, without the loss of its liquid helium coolant, means it can be up and running precisely when it is needed to treat patients. The Vida Imaging & Breast Center, which provides a wide range of medical imaging services, is a vital community asset that helps patients on the remote island of Puerto Rico receive high-quality healthcare.

“Puerto Rico has tropical storms every year. Philips BlueSeal magnet technology allows us to de-energize our MRI system to prepare the MRI department for this situation and restore operations quickly once it is safe, all from the MRI console,” said Dr. Mayra Maldonado, Owner/CEO at the Vida Imaging & Breast Center.

In the aftermath of a hurricane or other natural disaster, transport systems are disrupted, and obtaining helium, especially when transporting to remote locations, could take weeks. A conventional MRI scanner requires up to 1700 liters of liquid helium, much of which can be lost if the magnet has to be periodically shut down. A Philips BlueSeal magnet only requires a pre-load of 7 liters during manufacturing and loses none of it, even during a so-called magnet quench – a sudden loss of superconductivity in the magnet coil which rapidly boils the liquid helium. Philips’ AI-enabled [3] EasySwitch technology always ensures orderly shutdown and re-energizing of the magnet once the danger has passed.

With a magnet that is 900kg lighter than a traditional system [4], Philips MR systems equipped with BlueSeal magnets can also be installed in places that were previously unthinkable like elevated floors or indoor sites with construction limitations. This technology is even available in [5] that have the potential to expand quality access to MRI exams for patients in a more sustainable [2] way.

[1] Systems contain 7 liters of helium, fully sealed, no helium can leave the system.

[2] Compared to the Ingenia 1.5T ZBO magnet.

[3] According to the definition of the EU High-Level Expert Group on Artificial Intelligence.

[4] Compared to Philips earlier (non-BlueSeal) Ingenia 1.5T ZBO magnet.

[5] BlueSeal MR mobile unit 1.5T is considered a work in progress. It is not CE marked and not available for sale outside of the U.S.

For further information, please contact:





Kathy O’Reilly

Philips Global External Relations

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
30/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new...

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member April 2, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Carla Goulart Peron, MD, Chief Medical Officer at Philips, has been appointed to the of the Medical Device Innovation Consortium (). Founded in 2012, MDIC is a unique public-private partnership that brings stakeholders across the medical device spectrum together with the US Food and Drug Administration () and other agency partners to help ensure patient access to medical device inn...

 PRESS RELEASE

FDA clears Philips AI solution that provides real-time guidance during...

FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates with Philips Azurion image-guided therapy platform that combines imaging, real-time data and intelligent software within a unified workflow to support more consistent, efficient and confidently guided minimally invasive procedures Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA...

 PRESS RELEASE

Philips launches IntraSight Plus to simplify coronary interventions an...

Philips launches IntraSight Plus to simplify coronary interventions and advance precision care March 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient careWith FDA clearance and CE marking, IntraSight Plus streamlines the workflow efficiency of minimally invasive coronary procedures and can enable system operation time savings up to 47% in both the USA and Europe Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technolog...

 PRESS RELEASE

Philips remains No. 1 in Medtech at European Patent Office and the lar...

Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips’ platform-based solutions integrate hardware, software, data and AI to address clinical, operational and everyday health challenges.Philips’ innovation improved the lives of 2 billion people in 2025, with the goal of improving 2.5 billion lives per year by 2030, including 400 million people in medically unde...

 PRESS RELEASE

Philips convenes the Annual General Meeting of Shareholders 2026

Philips convenes the Annual General Meeting of Shareholders 2026 March 23, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as m...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch